Suppr超能文献

一种 Fc 工程改造方法,用于鉴定针对埃博拉病毒的体液免疫功能相关因素。

A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.

机构信息

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.

Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX, USA; Galveston National Laboratory, Galveston, TX, USA.

出版信息

Immunity. 2021 Apr 13;54(4):815-828.e5. doi: 10.1016/j.immuni.2021.03.009.

Abstract

Protective Ebola virus (EBOV) antibodies have neutralizing activity and induction of antibody constant domain (Fc)-mediated innate immune effector functions. Efforts to enhance Fc effector functionality often focus on maximizing antibody-dependent cellular cytotoxicity, yet distinct combinations of functions could be critical for antibody-mediated protection. As neutralizing antibodies have been cloned from EBOV disease survivors, we sought to identify survivor Fc effector profiles to help guide Fc optimization strategies. Survivors developed a range of functional antibody responses, and we therefore applied a rapid, high-throughput Fc engineering platform to define the most protective profiles. We generated a library of Fc variants with identical antigen-binding fragments (Fabs) from an EBOV neutralizing antibody. Fc variants with antibody-mediated complement deposition and moderate natural killer (NK) cell activity demonstrated complete protective activity in a stringent in vivo mouse model. Our findings highlight the importance of specific effector functions in antibody-mediated protection, and the experimental platform presents a generalizable resource for identifying correlates of immunity to guide therapeutic antibody design.

摘要

保护性埃博拉病毒 (EBOV) 抗体具有中和活性,并诱导抗体恒定区 (Fc) 介导的先天免疫效应功能。增强 Fc 效应功能的努力通常侧重于最大限度地提高抗体依赖性细胞毒性,然而,对于抗体介导的保护作用,不同的功能组合可能是至关重要的。由于已经从埃博拉病毒病幸存者中克隆出了中和抗体,因此我们试图确定幸存者的 Fc 效应功能谱,以帮助指导 Fc 优化策略。幸存者发展出了一系列功能性抗体反应,因此我们应用了一种快速、高通量的 Fc 工程平台来定义最具保护作用的功能谱。我们从一种埃博拉病毒中和抗体中生成了具有相同抗原结合片段 (Fab) 的 Fc 变体文库。具有抗体介导的补体沉积和适度自然杀伤 (NK) 细胞活性的 Fc 变体在严格的体内小鼠模型中表现出完全的保护活性。我们的研究结果强调了特定效应功能在抗体介导的保护中的重要性,并且该实验平台为鉴定免疫相关性提供了一种普遍适用的资源,以指导治疗性抗体设计。

相似文献

1
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.
Immunity. 2021 Apr 13;54(4):815-828.e5. doi: 10.1016/j.immuni.2021.03.009.
2
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.
Cell Host Microbe. 2018 Aug 8;24(2):221-233.e5. doi: 10.1016/j.chom.2018.07.009.
3
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors.
Front Immunol. 2021 May 20;12:682120. doi: 10.3389/fimmu.2021.682120. eCollection 2021.
4
Differential requirements for FcγR engagement by protective antibodies against Ebola virus.
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20054-20062. doi: 10.1073/pnas.1911842116. Epub 2019 Sep 4.
5
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
Front Immunol. 2019 Mar 22;10:548. doi: 10.3389/fimmu.2019.00548. eCollection 2019.
6
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.
Front Immunol. 2019 Mar 18;10:440. doi: 10.3389/fimmu.2019.00440. eCollection 2019.
7
Cell-targeting antibodies in immunity to Ebola.
Pathog Dis. 2016 Jun;74(4):ftw021. doi: 10.1093/femspd/ftw021. Epub 2016 Mar 21.
8
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization.
Immunity. 2020 Feb 18;52(2):388-403.e12. doi: 10.1016/j.immuni.2020.01.001. Epub 2020 Feb 4.
9
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.
Immunity. 2018 Aug 21;49(2):363-374.e10. doi: 10.1016/j.immuni.2018.06.018. Epub 2018 Jul 17.
10
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.
Vaccine. 2011 Apr 5;29(16):2968-77. doi: 10.1016/j.vaccine.2011.01.113. Epub 2011 Feb 15.

引用本文的文献

1
Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease.
Nat Commun. 2025 May 6;16(1):4199. doi: 10.1038/s41467-025-59560-1.
3
Combinatorial Fc modifications for complementary antibody functionality.
MAbs. 2025 Dec;17(1):2465391. doi: 10.1080/19420862.2025.2465391. Epub 2025 Feb 14.
5
Underappreciated layers of antibody-mediated immune synapse architecture and dynamics.
mBio. 2025 Jan 8;16(1):e0190024. doi: 10.1128/mbio.01900-24. Epub 2024 Dec 11.
7
Transforming vaccinology.
Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021.
8
Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.
Immunol Rev. 2024 Nov;328(1):221-242. doi: 10.1111/imr.13393. Epub 2024 Sep 13.
9
Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis.
Nat Microbiol. 2024 Sep;9(9):2369-2382. doi: 10.1038/s41564-024-01777-9. Epub 2024 Aug 22.
10
A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus.
Front Immunol. 2024 Jul 16;15:1429909. doi: 10.3389/fimmu.2024.1429909. eCollection 2024.

本文引用的文献

1
Human neutralizing antibodies elicited by SARS-CoV-2 infection.
Nature. 2020 Aug;584(7819):115-119. doi: 10.1038/s41586-020-2380-z. Epub 2020 May 26.
3
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.02015-19.
4
Differential requirements for FcγR engagement by protective antibodies against Ebola virus.
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20054-20062. doi: 10.1073/pnas.1911842116. Epub 2019 Sep 4.
5
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation.
J Immunol Methods. 2019 Oct;473:112630. doi: 10.1016/j.jim.2019.07.002. Epub 2019 Jul 10.
6
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses.
J Infect Dis. 2020 Jan 1;221(1):156-161. doi: 10.1093/infdis/jiz364.
7
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
Front Immunol. 2019 Mar 22;10:548. doi: 10.3389/fimmu.2019.00548. eCollection 2019.
10
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.
Cell Host Microbe. 2019 Jan 9;25(1):49-58.e5. doi: 10.1016/j.chom.2018.12.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验